Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Search results

Found 39 matches for

Learning games explaining the links between typhoid, sewage systems and food hygiene have won the gold prize at the Learning Technologies Awards 2020.

Learning Technologies Awards 2020 University of Oxford with Discover eLearning and RenderHeads Gold Winner: best learning game Judges verdict: Excellent design and graphics and straightforward game play. This was a strong and refreshing entry.

Prof Teresa Lambe OBE delivers the University of Notre Dame 2025 Graduate School Commencement Address

Last month, Professor Teresa Lambe OBE, the Calleva Head of Vaccine Immunology and Professor of Vaccinology & Immunology at the Oxford Vaccine Group at the University of Oxford, delivered an inspiring speech at the University of Notre Dame’s Graduate School’s annual Commencement Ceremony.

Study shows urgent change needed to reduce deaths from malaria and meningitis in comatose African children

Results of two parallel studies show that one in four African children hospitalised with malaria and coma have an additional infection, and that giving antibiotics with antimalarials could help reduce death rates of comatose children.

New Book Shines a Light on the Power of Pro-Vaccine Activism

A new book by Professor Samantha Vanderslott of the University of Oxford, Pro-vax, is set to redefine how we think about vaccination by spotlighting a critical but often-overlooked force: pro-vaccine activism.

Professor Teresa Lambe OBE elected to the Fellowship of the Academy of Medical Sciences

Professor Teresa Lambe OBE, Calleva Head of Immunology at the Oxford Vaccine Group, and Principal Investigator at the Pandemic Sciences Institute, has been elected a Fellow of the Academy of Medical Sciences, one of the most prestigious awards in the field.

More babies could die if rates of vaccination against whooping cough don’t increase

Babies and the most vulnerable are at risk of death if vaccination rates for whooping cough don't increase, according to experts at the University of Oxford.

Advancing a malaria vaccine for better global health outcomes

Professor Sue Ann Costa Clemens CBE, Chair of Global Health at the Department of Paediatrics and Head of Oxford Latam Research Group – a collaboration between Oxford and Brazil, aimed at strengthening our commitment to global health – met with His Excellency Antonio Patriota, Brazilian Ambassador to the UK, to discuss the co-development of a Malaria vaccine and advance public health outcomes in Brazil.

New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites

Scientists at the University of Oxford and the University of Edinburgh have launched a pioneering study that examines how the immune system responds to repeated malaria infections. The BIO-004 study is being run in partnership between the Department of Biochemistry (Draper Lab, based in the Kavli Institute for Nanoscience Discovery), the University of Edinburgh (Spence Lab, Institute of Immunology and Infection Research) and the Oxford Vaccine Group (part of the Department of Paediatrics). BIO-004 will provide a unique insight into how the immune system adapts over the first few malaria infections of life, learning to tolerate malaria parasites and developing natural immunity to severe illness.

FCDO Minister meets with vaccine researchers

Researchers from the Department of Paediatrics today welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.

New campaign hopes to boost jab numbers

Experts have launched a new campaign in a bid to boost waning vaccine uptake by giving people more information about how clinical trials work. Researchers hope to alleviate hesitancy by showing with a simple animation and comic the complex way vaccines are developed.

Oxford launches new vaccine trial to enhance design of flu & COVID-19 vaccines

A pioneering study into human immunity is being launched today by Oxford Vaccine Group at the University of Oxford. The study, called LEGACY03, is being funded by the Medical Research Council part of UK Research and Innovation. By investigating how lymph nodes work, and how they make responses to vaccines in younger and older people, it has the potential to improve vaccine design for different age groups significantly.

Future of Chair in Global Health secured with £5 million gift

The University of Oxford’s commitment to tackling major global health challenges has been strengthened following the endowment of a chair in global health and clinical development. The new permanent post was made possible by a £5 million donation from Brazilian healthcare organisation SAIL for Health.

First vaccine trial in older people launched for Middle East Respiratory Syndrome (MERS)

Researchers at the University of Oxford's Pandemic Sciences Institute have launched a new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS).

First in-human trials commence for CCHF vaccine

A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to human volunteers for the first time. The clinical trial of the ChAdOx2 CCHF vaccine aims to confirm its safety and understand how individuals develop immunity following vaccination.

University of Oxford partners with CEPI to counter the threat of future pandemics

The University of Oxford and the Coalition for Epidemic Preparedness Innovations (CEPI) have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.

Professor Sir Andrew Pollard reveals unique insights into the world of science in a new podcast

Oxford Vaccine Group and Pandemic Sciences Institute’s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.

COVID-19 vaccine messaging that focuses on personal benefits is most effective with those who are hesitant

For the one in ten who say they won’t take a COVID-19 vaccine, messaging that focuses on personal rather than collective benefits is more effective.

How do nucleic acid vaccines work?

Ever wondered what happens inside your cells when you are infected with a virus? Or wondered how the new COVID-19 vaccines work? The answer to both of these questions can be found in how our cells receive instructions to make proteins. Actually, our cells are a bit like factories...

Increasing vaccine uptake among ethnic minorities

Dr Samantha Vanderslott and Dr Seilesh Kadambari discuss their collaborative approach to providing ethnic minority groups with information on vaccines.

COVID-19: how to tackle vaccine hesitancy among BAME groups

Samantha Vanderslott, Andrew Pollard and Seilesh Kadambari discuss vaccine uptake among Black, Asian and minority ethnic communities in an article for The Conversation.

Oxford vaccine researchers talk research and home-schooling on ITV's This Morning

Professor Katie Ewer (The Jenner Institute) and Dr Maheshi Ramasamy (Oxford Vaccine Group) appeared on ITV's This Morning on Wednesday 6 January to talk about their work developing the ChAdOx1 nCoV-19 coronavirus vaccine, all while juggling the demands of young families and home-schooling.

Load More

Similar stories